Literature DB >> 33739007

Monitoring of C-reactive protein level (CRP) and Erythrocyte sedimentation rate (ESR) after total hip and knee arthroplasty.

F De Maio1, G Fidone1, A Caterini1, G Gorgolini1, L Petrungaro1, P Farsetti1.   

Abstract

C-reactive protein (CRP) and Erythrocyte sedimentation rate (ESR) are the two most commonly serum biomarkers for the diagnosis of periprosthetic joint infections (PJI). We monitored CRP and ESR in 60 patients affected by osteoarthritis who underwent primary total hip or knee arthroplasty to verify their utility for an early diagnosis of periprosthetic hip and knee infections. In all but two patients, both CRP and ESR increased rapidly after surgery, reaching a peak value around the 3rd day postoperatively; CRP decreased rapidly in 20 days, reaching normal value one month after surgery, while ESR decreased slowly, reaching the normal value after three months. In two patients, CRP and ESR were still elevated six months after the surgical procedure and in both cases a diagnosis of PJI was made. Our study confirms that postoperative screening of CRP and ESR values are very useful in making an early diagnosis of this serious complication. Copyright 2020 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  C-reactive protein; Erythrocyte sedimentation rate; periprosthetic joint infection

Mesh:

Substances:

Year:  2020        PMID: 33739007

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  2 in total

1.  Prediction of the Postoperative Fat Volume Retention Rate After Augmentation Mammoplasty with Autologous Fat Grafting: From the Perspective of Preoperative Inflammatory Level.

Authors:  Xiaoyu Zhang; Dali Mu; Yan Lin; Chenglong Wang; Boyang Xu; Yan Yang; Wandi Li; Yue Liu; Haoran Li
Journal:  Aesthetic Plast Surg       Date:  2021-10-01       Impact factor: 2.326

2.  Effect of storage temperature and time on erythrocyte sedimentation rate.

Authors:  Qi-Lei Hu; Zuo-Jie Li; Li Lin; Liang Zhang; Yin-Jiang Lv; Li-Feng Wu; Mei-Yun Chen
Journal:  Eur J Med Res       Date:  2022-05-28       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.